X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-04-19 | RNA | Levin Arthur A | Dir | S - Sale+OE | $22.82 | -5,000 | 268,702 | -2% | -$114,123 | |||||
2024-04-03 | RNA | Levin Arthur A | Dir | S - Sale | $27.11 | -20,000 | 268,702 | -7% | -$542,214 | ||||||
D | 2024-03-19 | RNA | Levin Arthur A | Dir | S - Sale+OE | $23.97 | -5,000 | 288,702 | -2% | -$119,848 | |||||
D | 2024-03-12 | RNA | Levin Arthur A | Dir | S - Sale+OE | $22.03 | -27,641 | 288,702 | -9% | -$609,017 | |||||
2024-01-22 | RNA | Levin Arthur A | Dir | S - Sale | $10.13 | -1,859 | 291,343 | -1% | -$18,832 | ||||||
D | 2023-03-15 | RNA | Levin Arthur A | Dir | S - Sale+OE | $22.01 | -100 | 293,202 | 0% | -$2,201 | |||||
D | 2023-02-14 | RNA | Levin Arthur A | Chief Scientific Officer | S - Sale+OE | $23.66 | -10,000 | 293,202 | -3% | -$236,567 | |||||
D | 2023-01-12 | RNA | Levin Arthur A | Chief Scientific Officer | S - Sale+OE | $22.00 | -10,000 | 275,202 | -4% | -$220,028 | |||||
D | 2022-12-29 | RNA | Levin Arthur A | Chief Scientific Officer | S - Sale+OE | $22.01 | -40,000 | 1,330 | -97% | -$880,568 | |||||
DM | 2022-08-12 | RNA | Levin Arthur A | Chief Scientific Officer | S - Sale+OE | $22.10 | -80,000 | 275,202 | -23% | -$1,767,666 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |